British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy
Open Access
- 1 October 2003
- journal article
- Published by Wiley in HIV Medicine
- Vol. 4 (S1), 1-41
- https://doi.org/10.1046/j.1468-1293.4.s1.3.x
Abstract
No abstract availableThis publication has 107 references indexed in Scilit:
- Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administrationBritish Journal of Clinical Pharmacology, 2001
- Substitution of a Nonnucleoside Reverse Transcriptase Inhibitor for a Protease Inhibitor in the Treatment of Patients with Undetectable Plasma Human Immunodeficiency Virus Type 1 RNAClinical Infectious Diseases, 2000
- O2 Comparison of viral drug resistance, adherence and PK indices in patients on successful and failing PI-based regimensHIV Medicine, 2000
- Rationale for the Use of Hydroxyurea as an Anti-Human Immunodeficiency Virus DrugClinical Infectious Diseases, 2000
- Letters to the Editor: Fatal lactic acidosis and liver steatosis associated with didanosine and stavudine treatment: a respiratory chain dysfunction?Journal of Hepatology, 2000
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997